---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-21-017730"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2021-11-12T23:59:59+00:00"
generated_at: "2026-06-28T08:55:24.100184+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Charles River Laboratories promotes Birgit Girshick to COO, adds Research Models & Services oversight

## Summary
- Birgit Girshick promoted to Executive VP and COO, effective November 11, 2021.
- She adds Research Models and Services to her existing responsibilities for Discovery, Safety Assessment, Biologics Solutions, and Cell & Gene Therapy CDMO.
- Girshick has been with Charles River since 1989, leading strategic initiatives and integrating acquisitions like Cognate BioServices and Vigene Biosciences.
- James C. Foster remains Chairman, President and CEO; his employment agreement was extended to February 2026.

## SEC filing metadata
- accession: 0000950103-21-017730
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2021-11-12T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000095010321017730/0000950103-21-017730-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000095010321017730/dp161684_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-21-017730
- JSON: https://secwatch.observer/filing/0000950103-21-017730.json
- Plain text: https://secwatch.observer/filing/0000950103-21-017730.txt

## Key facts
- Executive change
  Birgit Girshick was appointed as Chief Operating Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On November 11, 2021, Charles River Laboratories International, Inc. (the "Company") announced that Ms. Birgit Girshick, Corporate Executive Vice President, Discovery and Safety Assessment and Biologics Testing Solutions, will become Chief Operating Officer of the Company, effective immediately, and will add Research Models and Services to her responsibilities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1100682/000095010321017730/0000950103-21-017730-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.